Trial Profile
A Phase 2, Randomized, Double-blind, Placebo-controlled, Parallel Group, Fixed Dose Study of AMG 223 in Subjects With Chronic Kidney Disease on Hemodialysis With Hyperphosphatemia
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 15 Mar 2016
Price :
$35
*
At a glance
- Drugs Bixalomer (Primary)
- Indications Renal failure
- Focus Therapeutic Use
- Sponsors Amgen
- 22 Dec 2014 New trial record